I-Sofosbuvir
索非布韦 | I-Sofosbuvir | 1190307-88-0 | Endlini |
I-SFBM | 1256490-31-9 | Endlini | |
I-SFB-8 | 874638-80-9 | Endlini | |
I-SFB-10 | 817204-32-3 | Endlini | |
I-SFBA-1 | 863329-66-2 | Endlini | |
I-SFBMA | 1334513-02-8 | Endlini |
Igama elijwayelekile: sofosbuvir (soe FOS bue vir)
Amagama Brand: Sovaldi
I-Sofosbuvir umuthi ovimbela amagciwane osetshenziselwa ukwelapha isifo sokusha kwesibindi kohlobo C esingelapheki kubantu abadala nasezinganeni okungenani ezineminyaka engu-3 ubudala kanye ne-HCV RNA replication inhibitor ene-EC50 yama-92 nM.
I-Sofosbuvir kufanele inikezwe ngokuhambisana neminye imithi elwa namagciwane (imvamisa i-ribavirin ene-peginterferon alfa noma ngaphandle kwayo). I-Sofosbuvir akufanele isetshenziswe yodwa.
I-Sofosbuvir yelapha i-genotype ethile ye-hepatitis C, futhi kubantu abathile kuphela. Sebenzisa kuphela imithi oyinqunyelwe. Ungabelani ngomuthi wakho nabanye abantu.
I-Sofosbuvir ngezinye izikhathi isetshenziswa kubantu abane-HIV, noma abantu abanomdlavuza wesibindi futhi abazofakelwa isibindi. Lo muthi awukona ukwelashwa kwe-HIV noma i-AIDS.
Isitoreji
Impushana | -20°C | 3 iminyaka |
4°C | iminyaka engu-2 | |
Ku-solvent | -80°C | 6 izinyanga |
-20°C | Inyanga engu-1 |
Isakhiwo samakhemikhali





Isiphakamiso18Amaphrojekthi Wokuhlola Ukuvumelana Kwekhwalithi asegunyaziwe4, futhi6amaphrojekthi angaphansi kokugunyazwa.

Uhlelo lokuphatha ikhwalithi yamazwe ngamazwe oluthuthukile lwenze isisekelo esiqinile sokuthengisa.

Ukugadwa kwekhwalithi kusebenza kuwo wonke umjikelezo wempilo womkhiqizo ukuze kuqinisekiswe ikhwalithi nomphumela wokwelapha.

Ithimba Lezindaba Zokulawula Ochwepheshe lisekela izimfuno zekhwalithi ngesikhathi sokufaka isicelo nokubhaliswa.


I-Korea Countec Bottled Packaging Line


I-Taiwan CVC Bottled Packaging Line


I-Italy CAM Board Packaging Line

Umshini Wokuhlanganisa we-Fette waseJalimane

I-Japan Viswill Tablet Detector

I-DCS Control Room

